Skip to main content
Earnings Labs
Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ·Healthcare·Biotechnology

$4.59

+6.56%

Mkt Cap $7.91M

Analyst Ratings

No recent rating data.

Price Target (2 analysts)

$4.00

Range $1.00$7.00

Implied Upside

-12.9%

Consensus $4.00 vs current $4.59